Take Your Trading To The Next Level. Get Started Here!

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition

October 26, 2023 Comments Off

Bristol Myers Squibb’s revenue was in line with estimates, but fell slightly from the same period last year due to lower sales of blood cancer drug Revlimid.